Stempoint Capital »

Springworks Therapeutics shares owned by Stempoint Capital

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $7.0M 159k 44.13

More positions owned by Stempoint Capital

Roivant Sciences SHS (ROIV)
Uniqure Nv SHS (QURE)
Immunovant (IMVT)
Scholar Rock Hldg Corp (SRRK)
Denali Therapeutics (DNLI)
Syndax Pharmaceuticals (SNDX)
Biohaven (BHVN)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Wave Life Sciences SHS (WVE)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Ideaya Biosciences (IDYA)
Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Surrozen Com New (SRZN)

View all positions for Stempoint Capital

Top funds holding Springworks Therapeutics

DekaBank Deutsche Girozentrale
Sanctuary Advisors
Advisor Group Holdings
Huntington National Bank

View all funds holding Springworks Therapeutics